Effects of Saxagliptin on Adipose Tissue Inflammation in Humans
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 103 participants.
Also called NCT02285985
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 103 participants
- Sponsor
- Registry
-
NCT02285985
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02285985. Randomized; double masking; primary purpose treatment. Start 2013-02 (actual); primary completion 2019-10-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effects of Saxagliptin on Adipose Tissue Inflammation in Humans
- Condition
- Type 2 Diabetes Mellitus (T2DM)
- Intervention (Drug)
- Saxagliptin
- Intervention (Drug)
- Placebo
- Lead sponsor
- Phoenix VA Health Care System
- Collaborator
- Bristol-Myers Squibb
Record details
- Record id
cardio:ct-nct02285985- Content hash
daf727536b2ee5d81216b8b917ac27a5ad0968c8ae78c73424cc3fc0ef8b31bd